Preventive Physical Activity Intervention in Head and Neck Cancer
Preventive Randomized Study Regarding Physical Activity Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer: the Effect of Preventive Intervention for Physical Activity, Function and Quality of Life
1 other identifier
interventional
80
1 country
1
Brief Summary
The study includes patients with tumors of the oropharynx, larynx and hypopharynx scheduled to receive radiotherapy with curative intent (+/- chemotherapy). The patients will be randomized into either an intervention group (performing a preventive physical activity protocol before and during radiotherapy) or a control group not performing a specified physical exercise protocol. All patients will be in contact with with a speech language pathologist or a physical therapist weekly during radiotherapy. The study is expected to improve physical function and quality of life during and after oncologic treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2022
CompletedFirst Posted
Study publicly available on registry
June 27, 2022
CompletedStudy Start
First participant enrolled
January 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2032
April 23, 2026
April 1, 2026
4.9 years
April 12, 2022
April 22, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Objectively measured physical activity
Measured with an accelerometer. Measures time spent in different activities i minutes/day.
Up to 12 months
Subjectively measured physical activity - Saltin-Grimby
Measured with the Saltin-Grimby physical activity level scale and the International Physical Activity Questionnaire.
Up to 12 months
Subjectively measured physical activity (IPAQ)
Measured with the International Physical Activity Questionnaire
Up to 12 months
Secondary Outcomes (8)
Health related quality of life (HRQL) using the EORTC QLQ-C30
Up to 5 years post radiotherapy
Health related quality of life (HRQL) using the EORTC QLQ H&N35
Up to 5 years post radiotherapy
Trismus and jaw related symptoms
Up to 5 years post radiotherapy
Dysphagia related symtoms
Up to 5 years post radiotherapy
Maximal Interincisal opening (MIO)
Up to 5 years post radiotherapy
- +3 more secondary outcomes
Other Outcomes (4)
Cost
Up to 5 years post radiotherapy
Quality of life for cost-effectiveness analysis
Up to 5 years post radiotherapy
Quality Adjusted Life Years (QALY)
Up to 5 years post radiotherapy
- +1 more other outcomes
Study Arms (2)
Physical exercise intervention
EXPERIMENTALThe physical activity intervention is based on national guidelines of physical activity in cancer rehabilitation. A physiotherapist together with each patient will develop individual adaptations to the exercise protocol, with suggestions on which type of exercise the participant is able to perform depending on their daily condition. Suggestions on physical activity for good, bad and in-between-days will be listed in collaboration with the participant, and the participant will report number of minutes/day in each of the 3 physical activity levels stated.
Control
NO INTERVENTIONThe control group will receive general advice on the importance of physical activity during oncologic treatment, according to local clinical standard.
Interventions
Daily physical activity depending on daily condition
Eligibility Criteria
You may qualify if:
- Head and neck cancer (tumors of the oropharynx, pharynx, hypopharynx and larynx)
- Receiving radiohterapy (+/- chemotherapy) with curative intent
You may not qualify if:
- Surgery due to head and neck cancer
- Previous treatment for head and neck cancer
- Tracheostomized patients
- Inability to perform exercise intervention
- Inability to perform part of 6-minute walking test
- Inability to independently fill out questionnaires in Swedish
- Previous neurologic or neuromuscular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Tuomi, PhD
Sahlgrenska University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 12, 2022
First Posted
June 27, 2022
Study Start
January 2, 2023
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2032
Last Updated
April 23, 2026
Record last verified: 2026-04